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Objectives. This study sought o assess the short-term effect of 
discontinuing latissimus dorsi muscle stimulation on left ventric- 
ular systolic and diastolic performance and exercise tolerance in 
patients with improved functional status by cardiomyoplasty, in 
whom latissimus dorsi muscle was fully conditioned. 
Background. Cardiomyoplasty has consistently improved the 
functional status of patients, but the short-term effect of latissi- 
mus dorsi muscle contraction has not been assessed in these 
patients. 
Methods. Right-heart catheterization, Doppler- echocardiography 
and maximal exercise testing with expired gas analysis were per- 
formed in 10 patients with congestive heart failure who had under- 
gone cardiomyoplasty at least 6 months earlier. Data were obtained 
when the latissimus dorsi muscle was stimulated every other systole 
and after stimulation was discontinued for 1 h. The power of this 
study to detect a 10% difference was >80%. 
Results. After cardiomyoplasty, left ventricular ejection frac- 
tion increased from 0.22 _+ 0.08 (mean _+ SD) to 0.27 + 0.07 after 
6 months (p < 0.02 vs. before cardiomyoplasty) and to 0.24 -+ 0.09 
after 1 year; functional class went from 3.0 -+ 0.0 to 2.0 - 0.5 after 
6 months and to 2.0 -+ 0.7 after 1 year (both p < 0.001 vs. before 
cardiomyoplasty). After discontinuation of latissimus dorsi mus- 
cle stimulation, cardiac index did not change (2.28 _+ 0.45 vs. 
2.30 _+ 0.46 liters/min per m2). Mean systemic arterial and 
pulmonary capillary wedge pressures were also similar (85.2 - 6.0 
vs. 88.4 -+ 5.6 mm Hg and 14.9 -+ 7.1 vs. 13.6 -+ 6.8 mm Hg, 
respectively). Doppler E/A ratio decreased from 1.04 -+ 0.33 to 
0.83 + 0.25 (p < 0.02), suggesting that left ventricular diastolic 
function may have been improved by latissimus dorsi muscle 
stimulation. Peak oxygen consumption was unaltered (1,633 +- 
530 vs. 1,596 + 396 ml/min). 
Conclusions. Alterations in left ventricular diastolic rather 
than systolic function may be responsible for the long-term 
clinical benefits of cardiomyoplasty. 
(J Am CoU Cardiol 1995;26:129-34) 
Dynamic cardiomyoplasty is aimed at enhancing cardiac per- 
formance by assisting myocardial contraction (1). A pedicled 
latissimus dorsi muscle flap is placed around the heart and 
subsequently stimulated in synchrony with ventricular systole. 
Cardiomyoplasty has two major advantages over cardiac trans- 
plantation: 1) absence of immunologic rejection, and 2) con- 
stant availability of the latissimus dorsi muscle. Moreover, 
when the procedure fails, cardiac transplantation remains an 
option (2). Cardiomyoplasty has been shown to improve the 
functional status of patients (3-5) and may also favorably alter 
survival (5). The operative mortality rate has been decreased to 
<20% by careful patient selection (4). Besides enhancement of 
left ventricular systolic function (by direct mechanical ventric- 
ular compression), several potential beneficial effects include 
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prevention of further left ventricular dilation, resulting in turn 
in decreased wall stress and subsequent improvement of 
myocardial oxygen balance. However, to our knowledge the 
relative contribution of these different mechanisms has not 
been assessed (6,7). 
The present study was undertaken to assess the effects of 
short-term discontinuation of latissimus dorsi muscle stimula- 
tion on left ventricular systolic and diastolic performance in 
patients with fully conditioned latissimus dorsi muscle. They 
had undergone cardiomyoplasty at least 6 months earlier, so 
that the latissimus dorsi muscle conditioning had been com- 
pleted for a minimum of 2 months. Rest hemodynamic vari- 
ables, Doppler ventricular diastolic inflow and exercise capac- 
ity were measured during and after discontinuation of 
latissimus dorsi muscle stimulation. 
Methods  
Patients. Ten patients who had undergone cardiomyo- 
plasty a minimum of 6 months earlier (mean [+_SD] 9.5 _+ 3.1 
months) were studied. All patients were enrolled in the 
©1995 by the American College of ( ardi~logx 0735-1097/95/$9.50 
0735-1097(95)00117-M 
130 JONDEAU ET AL. JACC Vol. 26, No. 1 
DYNAMIC CARD1OMYOPLASTY July 1995:129-34 
multicenter Medtronic study (Maastricht, The Netherlands) and 
fulfilled entry criteria, including isotopic left ventricular ejection 
fraction <0.40, mean capillary wedge pressure or left ventricular 
end-diastolic pressure >15 mm Hg and New York Heart Asso- 
ciation functional class III despite optimal medical therapy. None 
of them had had concomitant surgical intervention. Mean age was 
51.2 _+ 7.3 years (range 43 to 63). Congestive heart failure was 
secondary to coronary artery disease in two patients and to 
idiopathic dilated cardiomyopathy in eight. Before cardiomyo- 
plasty, all patients were treated with angiotensin-converting en- 
zyme inhibitors and loop diuretic drugs. Six patients were given 
nitrates, ix amiodarone and three cardiac glycosides. At the time 
of the study, angiotensin-converting enzyme inhibitors were dis- 
continued in one patient because of severe symptomatic hypoten- 
sion; loop diuretic drugs were discontinued in one patient; six 
patients were receiving amiodarone, three digoxin, and only one 
was still receiving nitrates. All patients provided written informed 
consent, and the protocol was approved by the Comit6 d'l~thique 
de l'Universit6 Claude Bernard et des Hospices Civils de Lyon. 
Stimulation protocol. Two weeks after latissimus dorsi mus- 
cle implantation, stimulation was started every two systoles, with 
one impulse of 3.5 V/burst. The number of impulses was then 
increased every 2 weeks (by increasing the frequency of the burst 
from 5 to 30 Hz) until each burst included six impulses (burst 
duration 185 ms). The delay between the R wave detected by the 
sensing electrode placed on the right ventricle and the first 
impulse was set up so that the burst began at the onset of mitral 
valve closure on M-mode echocardiography. This timing was 
checked at each visit during follow-up. The impulse amplitude 
was increased systematically until it reached 4.5 V or if the patient 
requested it (one time) or if hemodynamic deterioration ccurred 
(two times). However, no patient could withstand impulses >5 V. 
At the time of the study, the mean amplitude of stimulation was 
4.23 V (range 3.5 to 5 V), and trains of six pulses were delivered 
in all patients. 
Hemodynamic study at rest. A Swan-Ganz catheter was 
inserted through a peripheral vein of the arm and advanced 
into the right pulmonary artery under fluoroscopic guidance. 
Pressures were measured with a Siemens Mingograph III or a 
Hewlett-Packard monitoring device and recorded uring end- 
expiration or held expiration. Systemic arterial pressures were 
obtained by cuff with an automated device (Dynamap). Car- 
diac output was measured by the thermodilution technique 
(Baxter-Edwards). Radial and pulmonary artery blood samples 
were withdrawn for gas analysis and for derivation of arterio- 
venous oxygen content difference. 
Echocardiographic-Doppler study at rest. Echocardiographic- 
Doppler studies were performed with an Interspec or a 
Hewlett-Packard machine with a 3.5-MHz duplex probe. Left 
ventricular echocardiographic diameter was measured in the 
parasternal long-axis view using the M-mode guided by two- 
dimensional echocardiography. Transaortic and transmitral 
flow velocities were recorded from the apical view. For mitral 
flow recording, the sampling volume was placed at the level of 
the mitral eaflet ips and just below the aortic valves for aortic 
flow recording. All studies were recorded on a 0.5-in. video- 
tape for subsequent analysis. 
Mitral flow was digitized and analyzed using a personal 
program, allowing calculation of A and E wave peak velocities; 
A and E acceleration and deceleration times; A, E and total 
velocity-time integrals; RR interval; and total filling time 
(mitral inflow duration). Similarly, aortic flow was digitized 
and analyzed according to a previously described technique 
(8), allowing calculation of acceleration, deceleration and 
ejection tin ~s; peak and mean aortic velocities; maximal and 
mean acceleration times; and RR interval. Six consecutive 
beats were averaged. Premature ventricular beats and the two 
following beats were avoided. 
Protocol. With the patient in the fasting state, the Swan- 
Ganz catheter was positioned in the pulmonary artery. A 
complete echocardiographic-Doppler study was performed 
(baseline), and hemodynamic data were obtained. Blood sam- 
ples were withdrawn from the radial and pulmonary arteries 
for gas analysis. The stimulator was then switched off, and the 
hemodynamic and Doppler variables were recorded after 1, 3 
and 5 min. Because of the technical impossibility of simulta- 
neously recording aortic and mitral Doppler flows, and pulmo- 
nary artery and pulmonary capillary wedge pressures, the 
stimulation was set on again for 30 min, and new transitions 
allowed the measurement of missing variables. After comple- 
tion of intermediary studies, the latissimus dorsi was left 
unstimulated for 1 h, and a complete set of hemodynamic and 
Doppler variables was obtained. The pulse generator was then 
switched back on. 
Exercise test. Exercise was conducted in a temperature- 
controlled room at 20 to 22°C. Exercise testing was performed 
in the upright position on a magnetically braked bicycle 
ergometer (Ergoline) with both feet secured to the pedals. All 
the patients were familiar with bicycle xercise testing and had 
undergone several previous tests with continuous expired gas 
analysis. Work rate was increased by 12.5 W/rain. 
Expired gas was collected continuously during exercise 
through a low resistance three-way valve (Hans Rudolph). 
Oxygen uptake and carbon dioxide production were deter- 
mined in ml/min at 15-s intervals (CPX Medical Graphics). 
Respiratory exchange ratio was calculated as carbon dioxide 
production/oxygen uptake. Every minute, the patient was 
asked to quantify the perceived intensity of exercise from 0 
(nothing) to 10 (maximal) (9). 
Blood pressure (standard cuff technique) and the electro- 
cardiogram were continuously monitored uring the exercise 
and recovery periods. Exercise tests with the cardiomyostimu- 
lator on and off were performed on separate days, at the same 
time of the day, in random order. 
Statistics. Data are reported as mean value + 1 SD. The 
measurements obtained when the stimulator was on and off for 
1 rain, 3 rain, 5 rain, and 1 h were compared with repeated- 
measures analysis of variance as well as measurements ob- 
tained before cardiomyoplasty and after 6 months and 1 year. 
A paired Student t test was used to compare 1) the measure- 
ments obtained when the stimulator had been discontinued for 
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Figure 1. Evolution of New York Heart Associa- 
tion functional class (left), left ventricular ejection 
fraction (middle) and peak oxygen consumption 
(right). 0 = values obtained before cardiomyo- 
plasty; +6 and +12 = values obtained 6 and 12 
months after cardiomyoplasty, respectively. After 6 
months, functional class improved significantly (p < 
0.01), as did mean left ventricular ejection fraction 
(p < 0.02). However, mean peak oxygen consump- 
tion remained unchanged. After l year, no signifi- 
cant change in peak oxygen consumption or ejec- 
tion fraction could be demonstrated. Symbols refer 
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1 h with those obtained when the stimulation was on, and 2) 
values obtained during the two exercise tests. 
This study was able to detect a 10% change in peak oxygen 
uptake or rest cardiac index with a power of 80%, according to 
the published reproducibility data for these measurements 
(10,11). 
Results 
After latissimus dorsi muscle implantation, radionuclide 
left ventricular ejection fraction increased from 0.22 _+ 0.08 up 
to 0.27 _ 0.07 at 6 months (p < 0.02 vs. before cardiomyo- 
plasty). However, after 1 year, it was no longer significantly 
different from the baseline value (0.24 _+ 0.09, p = NS). Mean 
functional class status improved from 3.0 to 2.0 _+ 0.5 after 6 
months and was 2.0 _+ 0.7 after 1 year (both p < 0.001 vs. 
before cardiomyoplasty) (Fig. 1). In contrast, after latissimus 
dorsi muscle implantation, rest cardiac output remained un- 
changed (2.4 _+ 0.4 liters/min per m 2 before cardiomyoplasty 
vs. 2.6 _+ 0.4 liters/min per m 2 after 6 months and 2.4 _ 0.5 
after 1 year, all p = NS) as well as peak oxygen consumption 
(18.9 _+ 3.7 ml/kg per min before cardiomyoplasty vs. 17.9 _+ 
2.2 ml/kg per min after 6 months and 18.3 _+ 3.1 after 1 year, 
all p = NS). Echocardiographic left ventricular end-diastolic 
diameters were not modified after cardiomyoplasty (72.8 _+ 
10.8 mm before cardiomyoplasty vs. 71.5 _+ 12.2 mm after 6 
months and 71.7 + 12.5 mm after 1 year). Similarly, rest heart 
rate remained stable. 
Hemodynamic study. Table 1 includes hemodynamic mea- 
surements with latissimus dorsi muscle stimulation off for 1 h. 
During latissimus dorsi muscle stimulation, arteriovenous 
oxygen content difference was 51 ml/liter. Systolic and diastolic 
pulmonary artery pressures averaged 31.0 _+ 9.8 and 16.2 _ 
7.3 mm Hg, respectively. Systolic and diastolic systemic blood 
pressures averaged 113 _+ 9 and 71 _+ 6 mm Hg, respectively. 
Systemic and pulmonary vascular resistance indexes aver- 
aged 1,457 _+ 277 and 113 _+ 36 dynes.s.cm -s, respectively. 
None of these variables were significantly altered 1, 3, 5 rain 
and 1 h after discontinuing the stimulation. Even when the 
three patients with the lowest cardiac index were considered 
(all <2.2 liters/min per m 2 and capillary wedge pressure 
>18 mm Hg), no effect was observed. 
Doppler study. Mitral flow. Three patients whose mitral 
regurgitation was graded 2+ or greater were excluded from 
mitral flow analysis, so that only data obtained from seven 
patients were analyzed. Heart rate and total filling time were 
not altered by stopping stimulation of latissimus dorsi muscle 
(Table 2). After discontinuation of latissimus dorsi muscle 
stimulation, left ventricular filling tended to occur later in 
diastole: although total velocity-time integral did not vary, 
E wave peak velocity decreased (p = 0.056), whereas A wave 
peak velocity was unchanged, so that the E/A velocity ratio 
decreased significantly (p < 0.02). Similarly, E wave velocity- 
time integral decreased (p < 0.001), whereas that for the A 
wave was not significantly modified. Despite the decrease in E 
wave peak velocity and velocity-time integral, E wave decel- 
Table 1. Hemodynamic Data 
HR BP PCWP CI PAS LVSWI SVR 
Stimulation (beats/rain) (mm Hg) (mm Hg) (ml/min per m 2) (ml3itcr) (g.m/m 2) (dynes.s.cm -s) 
On 
Mean 71 85.2 14.9 2.28 65.7 32.2 1,457 
_+SD _+10 =6.0 +7.1 _+0.45 +4.5 _+10.9 _+277 
Off 
Mean 69 88.4 13.6 2.30 65.3 35.4 1,533 
-+SD _+9.1 _+5.6 =6.8 _+0.46 _+5.4 =11.4 --381 
BP - blood pressure; CI - cardiac index; HR = heart rate; LVSWI - left ventricular stroke work index; PAS = pulmonary artery blood oxygen saturation; 
PCWP = pulmonary capillary wedge pressure; Stimulation = stimulation of latissimus dorsi muscle every other systole (On), and off for 1 h (Off); SVR = systemic 
vascular esistance. 
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Tab le  2. Mitral Doppler Data (mean + SD) 
Stimulation Stimulation p 
On Off 1 h Value 
RR (s) 0.89 -+ 0.13 0.88 + 0.14 NS 
Filling time (s) 0.48 _+ 0.13 0.45 + 0.ll NS 
VTI (cm) 13.3 + 2.9 12.3 + 2.0 NS 
VTI E (cm) 8.3 _+ 1.0 7.4 + 0.9 < 0.01 
VTI A (cm) 5.1 + 2.3 4.9 ± 1.2 NS 
E velocity (m/s) 0.54 + 0.10 0.48 + 0.10 0.056 
A velocity (m/s) 0.56 + 0.12 0.60 _+ 0.11 NS 
VEfVA 1.04 _+ 0.33 0.83 + 0.25 < (I.02 
RR = RR interval duration: VE/VA = ratio of maximal E wave velocity to 
maximal A wave velocity; VT1 = velocity-time integral; other abbreviations as in 
Table 1. 
eration time remained stable, suggesting that left ventricular 
relaxation was delayed after discontinuation of latissimus dorsi 
muscle stimulation. 
Aortic flow. Aortic flow variables were unchanged by dis- 
continuing latissimus dorsi muscle stimulation for 1, 3, 5 ±in or 
1 h. Aortic velocity-time integral and RR intervals pecifically 
remained unchanged, and this was consistent with the stability 
of the thermodilution cardiac output. 
Exercise studies. Exercise was limited by general fatigue or 
leg discomfort, or both, in all patients. None had symptoms 
compatible with angina or peripheral vascular disease. Discon- 
tinuing latissimus dorsi muscle stimulation for 1 h did not 
produce any symptom in any patient (Table 3). 
At maximal exercise, the muscle flap was contracting every 
two systoles in one test, every three systoles in seven tests and 
every four systoles in two tests. Discontinuation of latissimus 
dorsi muscle stimulation did not affect maximal exercise vari- 
ables. Derived variables, such as rate-pressure product or 
oxygen pulse, the latter being an indirect estimate of left 
ventricular stroke volume, also remained unchanged (18,667 .+ 
4,833 vs. 19,242 _ 5,515 [beats/min].mm Hg and 11.4 + 3.0 vs. 
11.2 .+ 2.2 ml/beat, respectively). 
The anaerobic threshold was identified in all patients but 
one. At anaerobic threshold, the heart-muscle flap contraction 
ratio was 1:3. Exercise variables at anaerobic threshold, includ- 
ing ovgen pulse (9.0 .+ 2.1 vs. 9.2 .+ 2.4 ml/beat), were 
unchanged by discontinuation of latissimus dorsi muscle stim- 
ulation. However, at anaerobic threshold the perceived inten- 
sity of exercise tended to be lower during the stress test 
performed when latissimus dorsi muscle stimulation was on 
(3.7 .+ 3.0 on vs. 4.9 _+ 3.4 off, p -- NS). 
Discuss ion  
Our study clearly indicates that discontinuation of latissi- 
mus dorsi muscle stimulation for 1 h did not alter rest left 
ventricular systolic function in patients with congestive heart 
failure who had undergone cardiomyoplasty at least 6 months 
earlier. In contrast, echocardiographic-Doppler-derived vari- 
ables of left ventricular diastolic function were altered by 
discontinuation of latissimus dorsi muscle stimulation in the 
absence of change in loading conditions of the heart, 
St imu la t ion  on  versus  off. The short-term hemodynamic 
effects of latissimus dorsi muscle stimulation, using a heart 
muscle flap contraction ratio of 1:1, have been studied in 
several animal models with variable results. Many investigators 
have reported an increase in cardiac output in both failing and 
nonfailing hearts (12-15), but others have not (16,17). Of note, 
animal models using unconditioned skeletal muscle may not be 
relevant to the human clinical situation because the rate of 
contraction and relaxation is slowed in conditioned skeletal 
muscle (18). In 21 patients alive >2 years after cardiomyo- 
plasty (4), stimulation of the latissimus dorsi muscle with 1:2 
ratio was reported to increase cardiac output by 12 .+ 3% 
Table 3. Exercise Data (mean + SD) 
HR SBP 
Stimulation (beats,±in) RER (ram Hg) 
Oxygen Oxygen 
Uptake Work Pulse 
(±l/rain) (W) (±l/beat) RPE 
On 
Rest t~ I 0.86 1113 342 
± 13 20.(19 ± 13 ±81 
AT 120 (}.95 i 18 1,044 
=7 ±0.05 ± 14 ±237 
Peak 142 1.15 131 1,633 
218 ±0.07 +_26 ±530 
Off 
Rest 85 0.87 98 334 
2 15 ±0.08 +9 +_72 
AT 116 0.95 123 1,046 
212 20.05 212 _+240 
Peak 142 1.19 134 1596 
+~ ±26 _.3 20.11 2396 
- -  3.9 - -  
+ l .1  
62 9.0 3.7 
214 +2.1 ±3.0 
115 ll.4 9.4 
z35 23.0 ±1.7 
- -  4.0 - -  
±1.1 
64 9.2 4.9 
+16 ±2.4 23.4 
117 11.2 9.7 
±32 +2.2 21.0 
AT = anaerobic threshold; RER = respirator' s exchange ratio: RPE = rate perceived exertion (10); SBP = systolic 
blood pressure: other abbreviations as in Table 1. 
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compared with values recorded after discontinuation f latis- 
simus dorsi muscle stimulation. Bocchi et al. (19) reported a
decrease inangiographic left ventricular ejection fraction after 
a discontinuation f 1:1 latissimus dorsi muscle stimulation for 
24 h. 
Preoperative versus postoperative findings. Cardiac out- 
put or left ventricular ejection fraction, or both, have been 
reported to increase after cardiomyoplasty in humans (4,19,20) 
and animal models of heart failure (21). In our patients, 
cardiac output remained unchanged, whereas mean left ven- 
tricular ejection fraction increased significantly from 0.22 _+ 
0.08 preoperatively to0.27 _+ 0.07 after 6 months (Fig. 1). This 
finding might suggest that the main effect of cardiomyoplasty 
was either an increase in mitral regurgitation r a decrease in 
left ventricular volume (not substantiated by a decrease in left 
ventricular end-diameter measured with M-mode echocardi- 
ography). However, these measurements are approximate be- 
cause of geometric changes of the left ventricle. The reason for 
the absence of a sustained improvement of left ventricular 
ejection fraction after 1 year is unclear and could merely be 
related to the small number of patients tudied. 
Diastolic function. In seven patients, mitral regurgitation 
was absent or minimal, and because preload and afterload 
estimated by mean capillary wedge and blood pressures were 
unchanged, as was diastolic filling time, left ventricular end- 
diastolic function could be assessed using Doppler mitral 
inflow velocity. Left ventricular filling tended to occur later 
after discontinuation f latissimus dorsi muscle stimulation, 
suggesting that contraction ofthe skeletal muscle improved left 
ventricular filling: The peak velocity and velocity-time integral 
of the E wave significantly decreased after latissimus dorsi 
muscle contraction stopped, and E/A ratio decreased, suggest- 
ing that at least left ventricular diastolic function was not 
impaired by muscle contraction. This is in keeping with the 
increase in peak filling rate reported by Cheng et al. (21) in an 
animal model of congestive heart failure. 
Exercise. Discontinuing latissimus dorsi muscle stimula- 
tion did not alter maximal graded stress test variables. The 
stability of peak oxygen consumption suggests that muscle 
stimulation did not impair left ventricular filling during exer- 
cise so as to reduce cardiac output and exercise capacity, and 
this is in keeping with our echocardiographic-Doppler study at 
rest. Furthermore, the finding that peak oxygen consumption 
was not higher with stimulation on is consistent with the 
hypothesis that muscle stimulation did not improve left ven- 
tricular systolic performance during exercise. This may result 
either from the absence of effect of muscle contraction on 
hemodynamic variables, as suggested by our study at rest, or 
from the low stimulation rate of the skeletal muscle flap, 
limited to 55/min and therefore occurring every three systoles 
at the anaerobic threshold or even less at maximal exercise. 
Alternatively, peak oxygen consumption might be unchanged 
because, similar to patients with severe heart failure, our 
patients were limited by peripheral factors, so that a short-term 
change in cardiac output would not be associated with a 
corresponding change in peak oxygen consumption (22-24). 
However, our patients were less severely limited than patients 
with congestive heart failure in whom such a peripheral 
limitation has been demonstrated (25). 
The absence of any effect of muscle flap contraction on left 
ventricular systolic performance is not readily explainable by 
technical factors. The surgical technique and conditioning 
protocol used were those developed by Chachques et al. (26). 
The mean amplitude of stimulation was 4.23 V, a value similar 
to that used by Carpentier et al. (4) (4.0 _+ 0.6 V), which has 
been reported to produce hemodynamic benefit in humans 
(27). The delay between operation and hemodynamic studies 
was >3 months, and according to Jatene et al. (28), most of the 
beneficial effect occurred at 3 months and was maintained 
thereafter. Because hemodynamic variables at rest were sub- 
normal, one can speculate that no distinct change could be 
expected. However, in three of our patients with a cardiac 
index <2.2 liters/min per m 2 and a mean pulmonary capillary 
wedge pressure >18 mm Hg, discontinuing latissimus dorsi 
muscle stimulation did not alter hemodynamic variables. One 
possible reason for this lack of efficacy could be, as suggested 
by Magovern et al., that the distal half of the muscle graft does 
not contract to the same degree as its proximal half or even 
lengthen, with most of the shortening occurring in the proximal 
part (18). 
Conclusions. Our study suggests that the improvement in 
left ventricular function reported in patients after cardiomyo- 
plasty is not directly related to dynamic ompression of the left 
ventricle by latissimus dorsi muscle, as initially proposed. No 
short-term effect of skeletal muscle stimulation (with the 
variables used during clinical follow-up) could be evidenced on 
rest hemodynamic or exercise stress test variables. The func- 
tional improvement reported by our patients may thus not 
reflect he mechanical ction of the muscle flap contraction on 
left ventricular systolic function. A myocardial oxygen 
consumption-saving effect has been reported (29), and some 
experiments suggest hat preventing further left ventricular 
dilation may be the main effect of cardiomyoplasty. Our 
Doppler studies uggest that cardiomyoplasty might improve 
left ventricular diastolic function. 
We thank Philippe Aegerter and Alain Beauchet for statistical assistance. 
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